Auspex Pharmaceuticals, Inc. (NASDAQ: ASPX) shares surged 41.8% to $100.52 after Teva Pharmaceutical Industries Limited announced its plans to acquire Auspex Pharmaceuticals for $101 per share. Share volume was 343,000, compared to an all-day average of 76,000
